Chemistry: molecular biology and microbiology – Maintaining blood or sperm in a physiologically active state...
Reexamination Certificate
2007-06-29
2010-12-28
Saucier, Sandra (Department: 1651)
Chemistry: molecular biology and microbiology
Maintaining blood or sperm in a physiologically active state...
Reexamination Certificate
active
07858295
ABSTRACT:
The present invention provides modified platelets having a reduced platelet clearance and methods for reducing platelet clearance. Also provided are compositions for the preservation of platelets. The invention also provides methods for making a pharmaceutical composition containing the modified platelets and for administering the pharmaceutical composition to a mammal to mediate hemostasis.
REFERENCES:
patent: 4344936 (1982-08-01), Soslau
patent: 4447415 (1984-05-01), Rock et al.
patent: 4695460 (1987-09-01), Holme
patent: 5089146 (1992-02-01), Carmen et al.
patent: 5576213 (1996-11-01), Stossel et al.
patent: 5622867 (1997-04-01), Livesey et al.
patent: 5876676 (1999-03-01), Stossel et al.
patent: 5919614 (1999-07-01), Livesey et al.
patent: 7018985 (2006-03-01), Boyer et al.
patent: 2004/0137557 (2004-07-01), DeFrees et al.
patent: 2004/0185036 (2004-09-01), Stossel et al.
patent: WO 94/18829 (1994-09-01), None
patent: WO 96/13158 (1996-05-01), None
patent: WO 2004/043381 (2004-05-01), None
patent: WO 2006/029233 (2006-03-01), None
Aas et al., “Survival of Blood Platelets Labeled with Chromium 51”, J. Clin. Invest., Sep. 1958, vol. 37, pp. 1257-1268.
PCT International Search Report—(PCT/US2005/037241) Date of Mailing May 1, 2006.
Supplementary Partial European Search Report—(EP 05811897) Date of completion of the search Feb. 29, 2008.
Mester, et al., “Role of sialic acid in the mechanism of platelet aggregation”, XP002471056, retrieved from STN Database accession No. 1973:544679, Database CA [Online] Chemical Abstracts Service, Columbus, Ohio, US.
Hartwig, J.H. et al.; “Association of Gelsolin with Actin Filaments and Cell Membranes of Macrophages and Platelets,” J. Cell Biol., 108(2): 467-479, Feb. 1989.
Hoffmeister, K.M. et al.; “Chilled Apoptotic and Senescent Platelets Clear by Distinct Mechanisms,” Blood, W.B. Saunders and Company, Orlando, FL, 96(11) Part 1: 658A, Nov. 16, 2000q.
Hoffmeister, K.M. et al.; “Mechanisms of Cold-Induced Platelet Actin Assembly,” J. Biol. Chem., 276(27): 24751-24759, Jul. 6, 2001.
Apitz-Castro, R. et al.; “Metabolic Isotopic Labelling of Plasma Membrane Glycoproteins from Normal, Glanzmann's and Bernard-Soulier Platelets,” Thrombosis Research, 16: 715-725, Pergamon Press Ltd. 1979.
Karpatkin, S. et al.; “Glycogenesis and Glyconeogenesis in Human Platelets: Incorporation of Glucose, Pyruvate, and Citrate into Platelet Glycogen; Glycogen Synthetase and Fructose-1,6-Diphosphatase Activity,” J. of Clinical Investigation, vol. 49(1970), pp. 140-149.
International Search Report of International Application No. PCT/US03/35629, mailed Nov. 4, 2004.
Soslau, G. et al.; “In Vitro Incorporation of Fucose and Methionine into Human Platelet Proteins,” Biochemical and Biophysical Research Communications, vol. 109, No. 4 (Dec. 31, 1982), pp. 1256-1263.
International Search Report (PCT/US06/40579); Date of Mailing: May 10, 2007; 3 pages.
EPO Search Report for 05811897 dated Mar. 17, 2008, 8 pages.
Andre, et al., “CD40L stabilizes arterial thrombi by a beta3 integrin—dependent mechanism”, Nat Med, Mar. 2002, vol. 8, pp. 247-252.
Baker, et al., “A Simple, Fluorescent Method to Internally Label Platelets Suitable for Physiological Measurements”, Am. J. Hem, Sep. 1997, vol. 56, pp. 17-25.
Berger, et al., “P-Selectin and platelet clearance”, Blood, Dec. 1998, vol. 92, pp. 4446-4452.
Bergmeier, et al., “Rhodocytin (aggretin) activates platelets lacking alpha2 betal integrin, glycoprotein VI, and the ligand-binding domain of glycoprotein Ibalpha”, J. Biol. Chem. Jul. 2001, vol. 276, pp. 25121-25126.
Bergmeier, et al., “Structural and functional characterization of the mouse von Willebrand factor receptor GPIb-IX with novel monoclonal antibodies”, Blood, 2000, vol. 95, pp. 886-983.
Berman, et al., “A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. Characterization and subcellular localization of platelet activation-dependent granule-external membrane protein”, J Clin Invest., 1986, vol. 78, pp. 130-137.
Berry, et al., “Endogenous synthesis of galactose in normal men and patients with hereditary galactosaemia”, Lancet, Oct. 1995, vol. 346, pp. 1073-1074.
Brown, et al., “Constitutive death of platelets leading to scavenger receptor-mediated phagocytosis. A caspase independent program”, J. Biol. Chem., Feb. 2000, vol. 275, pp. 5987-5995.
Corbi, et al., “The human leukocyte adhesion glycoprotein Mac-1 (complement receptor type 3, CD11b) alpha subunit. Cloning, primary structure, and relation to the integrins, von Willebrand factor and factor B”, J. Biol. Chem., Sep. 1988, vol. 263, pp. 12403-12411.
Coxon, et al., “A novel role for the [beta]2 integrin CDI Ib/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation”, Immunity, Dec. 1996, vol. 5, pp. 653-666.
Denis, et al., “A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis”, Proc Natl Acad Sci U S A., Aug. 1998, vol. 95, pp. 9524-9529.
Dumont, et al., “Platelet surface P-selectin measurements in platelet preparations: an international collaborative study. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion (ISBT)”, Transfus Med Rev, Jan. 1999, vol. 13, pp. 31-42.
Ellies, et al., “Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands”, PNAS, Jul. 2002, vol. 99, pp. 10042-10047.
Engelfriet, et al., “Bacterial contamination of blood components”. Vox Sang, 2000, vol. 78, pp. 59-67.
Greenberg & Jamieson, “The effects of various lectins on platelet aggregation and release”, Biochim. Biophys. Acta, Apr. 1974, vol. 345, pp. 231-242.
Hartwig, et al., “Thrombin receptor ligation and activated Rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets”, Cell, 1995, vol. 82, pp. 643-653.
Hartwig & Desisto, “The cytoskeleton of the resting human blood platelet: Structure of the membrane skeleton and its attachment to actin filaments”, J. Cell Biol., Feb. 1991, vol. 112, pp. 407-425.
Hartwig, et al., “D3 phosphoinositides and outside-in integrin signaling by GPHb/IIIa mediate platelet actin assembly and filopodial extension induced by phorbol 12-myristate 13-acetate”, J. Biol. Chem., 1996, vol. 271, pp. 32986-32993.
Heilmann, et al., “Fluorescein derivatization of fibrinogen for flow cytometric analysis of fibrinogen binding to platelets”, Cytometry, Dec. 1994, vol. 17, pp. 287-293.
Hoffmeister, et al., “The clearance mechanism of chilled blood platelets”, Cell, Jan. 2003, vol. 112, pp. 87-97.
Hoffmeister, et al., “Glycosylation Restores Survival of Chilled Blood Platelets”,Science, Sep. 12, 2003, vol. 301, pp. 1531-1534.
Jacobs, et al., “Don't bug me: the problem of bacterial contamination of blood components-challenges and solutions”, Transfusion, 2001, vol. 41, pp. 1331-1334.
Janmey & Stossel, “Gelsolin-polyphosphoinositide interaction. Full expression of gelsolin-inhibiting function by polyphosphoinositides in vesicular form and inactivation by dilution, aggregation, or masking of the inositol head group”, J. Biol. Chem., 1989, vol. 254, pp. 4825-4831.
Jaremo, et al., “Correlation of light transmission changes to changes of platelet glycoprotein Ib during storage of platelet concentrates”, Thromb Res, Mar. 1993, vol. 69, pp. 467-477.
Josefsson, et al., “The macrophage alphaMbeta2 integrin alphaM lectin domain mediates the phagocytosis of chilled platelets”, J. Biol. Chem., May 2005, vol. 280, pp. 18025-18032.
Korrel, et al., “Identification of a tetrasialyl
Clausen Henrik
Hartwig John H.
Hoffmeister Karin M.
Stossel Thomas P.
Ewing James F.
Foley & Lardner LLP
Morency Michel
Saucier Sandra
Velico Medical, Inc.
LandOfFree
Methods for prolonging survival of platelets using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for prolonging survival of platelets using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for prolonging survival of platelets using... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4217561